23 results on '"Grisanti S"'
Search Results
2. 1206 - oMtFSFI: Operated male to female sexual function index. Development and validation of the first questionnaire to assess sexual function after male to female gender reassignment surgery
3. OA05.04 Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non-Small Cell Lung Cancer: Preliminary Results of the EVOKE-02 Study.
4. 1454P Radiomic analysis predicts response to immunotherapy in metastastic non-small cell lung cancer (mNSCLC): Preliminary results.
5. V33 - Robot-assisted living donor nephrectomy and renal transplantation in a twin operating room: Preliminary experience
6. 2MO EO2401 (EO) therapeutic vaccine for patients (pts) with adrenocortical carcinoma (ACC) and malignant pheochromocytoma/paraganglioma (MPP): Phase I/II SPENCER study.
7. EP08.02-172 Effect of EGFR Inhibition on Bone Health in NSCLC Patients without Skeletal Metastasis.
8. 8728 The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM) – retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT).
9. 3069 Oral mucositis a side effect in Tyrosin-Kinase Inhibitor Therapy (Sunitinib): the role of assessment of symptoms in evaluation of toxicity.
10. OC-30: Circulating Tumor Cells in Locally Advanced Head and Neck Cancer: A Possible Role to Predict Response to the Treatment.
11. 245 Three drugs schedulein metastatic colorectal cancer (MCC). A phase II study of sequential Irinotecan (CPT11), oxaliplatin (I-OHP) plus folinic acid (FA) and short fluorouracil (5FU) infusion.
12. 1301P BRAF-mutant metastatic non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database.
13. 1283P Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.
14. Book review: Retinale Gefäßerkrankungen.
15. 516MO Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, combined with osimertinib, as first-line therapy or after progression on osimertinib in non-small cell lung cancer (NSCLC).
16. 1124P Pralsetinib in RET fusion-positive non-small cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP).
17. 664P A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era.
18. 318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
19. PH-0038: RT and concomitant CDDP vs cetuximab for head and neck cancer: long term outcomes of a randomized PH. II trial.
20. P54 - oMtFSFI: Operated Male to Female Sexual Function Index. Development and validation of the first questionnaire to assess sexual function after male to female gender reassignment surgery.
21. V46 - A multi-center analysis on surgical technique, outcomes and learning curve of male-to-female penoscrotal vaginoplasty.
22. SINGLE NUCLEOTIDE POLYMORPHISMS IN THE XRCC1 AND RAD51 GENES ARE ASSOCIATED WITH CLINICAL RADIOSENSI-TIVITY IN HEAD AND NECK CANCER
23. ASSOCIATION BETWEEN GENETIC POLYMORPHISMS IN THE XRCC1, XRCC3, RAD51 AND GSTP1 GENES AND CLINICAL RADIOSENSITIVITY IN HEAD AND NECK CANCER PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.